Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 3
2005 4
2006 2
2007 2
2008 4
2009 1
2011 1
2012 1
2013 4
2014 2
2015 5
2016 3
2017 8
2018 7
2019 11
2020 11
2021 12
2022 24
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: nishimura y. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: nishimura y. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
The Link Between Periodontal Inflammation and Obesity.
Iwashita M, Hayashi M, Nishimura Y, Yamashita A. Iwashita M, et al. Among authors: nishimura y. Curr Oral Health Rep. 2021;8(4):76-83. doi: 10.1007/s40496-021-00296-4. Epub 2021 Oct 1. Curr Oral Health Rep. 2021. PMID: 34611505 Free PMC article. Review.
Takotsubo Syndrome in Octogenarians and Nonagenarians.
Nishimura YK, Kubokawa SI, Imai RI, Nakaoka Y, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kawai K, Hamashige N, Doi Y. Nishimura YK, et al. Circ Rep. 2021 Nov 6;3(12):724-732. doi: 10.1253/circrep.CR-21-0090. eCollection 2021 Dec 10. Circ Rep. 2021. PMID: 34950798 Free PMC article.
Takotsubo Syndrome in Octogenarians and Nonagenarians - Reply.
Nishimura YK, Kubokawa SI, Kawai K, Hamashige N, Doi Y. Nishimura YK, et al. Circ Rep. 2022 Mar 17;4(4):186. doi: 10.1253/circrep.CR-22-0017. eCollection 2022 Apr 8. Circ Rep. 2022. PMID: 35434412 Free PMC article. No abstract available.
Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia.
Kidoguchi K, Kubato Y, Nishimura Y, Kizuka-Sano H, Kimura S. Kidoguchi K, et al. Among authors: nishimura y. Turk J Haematol. 2021 Feb 25;38(1):83-85. doi: 10.4274/tjh.galenos.2020.2020.0446. Epub 2020 Nov 9. Turk J Haematol. 2021. PMID: 33161683 Free PMC article. No abstract available.
Inhibition of CYP3A-mediated Midazolam Metabolism by Kaempferia Parviflora.
Kashiwabuchi Y, Nishimura Y, Kurata N, Iwase M, Kiuchi Y, Nobe K. Kashiwabuchi Y, et al. Among authors: nishimura y. Food Saf (Tokyo). 2022 Mar 3;10(1):32-41. doi: 10.14252/foodsafetyfscj.D-21-00013. eCollection 2022 Mar. Food Saf (Tokyo). 2022. PMID: 35510070 Free PMC article.
119 results